Laurus Labs Ltd. Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹1601.2Market Cap
₹ 86,505 Cr.Stock P/E
79.1ROE
18.3 %RSI
54.62Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients (APIs) including anti-retroviral, oncology drugs (including High Potent APIs), Cardiovascular, and Gastro therapeutics. They also offer integrated CMO and CDMO services to Global Innovators from Clinical phase drug development to commercial manufacturing. Laurus employs 6,500+ people, including around 1,050+ scientists, at more than 11 facilities approved by global agencies USFDA, WHO-Geneva, Japan-PDMA, UK-MHRA, EMA, TGA etc. [1]
Laurus Labs Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Laurus Labs Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Laurus Labs Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 1601.2 |
| RSI (14) | 54.62 |
| 50 DMA | 1451.47 |
| 200 DMA | 1137.8 |
| Trend | Bullish |
| A/D Rating | A |
| RS Rating | 50 |
| EPS Rating | 50 |
| TI65 | 1.13 |
| TI65 Trend | Bullish |
Pivot Points Analysis
Daily pivot points for Laurus Labs Ltd. calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹1677.6 |
| R2 | ₹1643.8 |
| R1 | ₹1622.5 |
| PP | ₹1588.7 |
| S1 | ₹1567.4 |
| S2 | ₹1533.6 |
| S3 | ₹1512.3 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 86,505 Cr. |
| Current Price | ₹ 1,601 |
| High / Low | ₹ 1,610 / 810 |
| Stock P/E | 79.1 |
| Book Value | ₹ 98.2 |
| Dividend Yield | 0.12 % |
| ROCE | 17.8 % |
| ROE | 18.3 % |
| Face Value | ₹ 2.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Jun 2023 | 1,182 | 27 | 14% |
| Sep 2023 | 1,224 | 37 | 15% |
| Dec 2023 | 1,195 | 23 | 15% |
| Mar 2024 | 1,440 | 75 | 17% |
| Jun 2024 | 1,195 | 13 | 14% |
| Sep 2024 | 1,224 | 20 | 15% |
| Dec 2024 | 1,415 | 93 | 20% |
| Mar 2025 | 1,720 | 233 | 24% |
| Jun 2025 | 1,570 | 162 | 24% |
| Sep 2025 | 1,653 | 194 | 24% |
| Dec 2025 | 1,778 | 252 | 27% |
| Mar 2026 | 1,812 | 282 | 28% |
| Jun 2026 | 2,026 | 362 | 32% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 30.64% |
| FIIs | 9.79% |
| DIIs | 43.99% |
| Public | 15.58% |
| No. of Shareholders | 56,722 |
Pros and Cons
Pros
- Healthy return on equity of 18.3% indicating strong capital allocation efficiency.
- Strong technical momentum with price holding comfortably above the 50 DMA (1451.47).
Cons
- Valuation metrics appear elevated with a trailing P/E of 79.1, demanding high performance requirements.
Related NSE Stocks
Piramal Pharma Ltd.
View Share Price Analysis →Jubilant Ingrevia Ltd.
View Share Price Analysis →HDFC Life Insurance Company Ltd.
View Share Price Analysis →Hitachi Energy India Ltd.
View Share Price Analysis →NMDC Ltd.
View Share Price Analysis →JM Financial Ltd.
View Share Price Analysis →Shipping Corporation of India Ltd.
View Share Price Analysis →Varun Beverages Ltd.
View Share Price Analysis →Choice International Ltd.
View Share Price Analysis →Tata Steel Ltd.
View Share Price Analysis →Reliance Industries Ltd.
View Share Price Analysis →International Gemological Institute Ltd.
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Laurus Labs Ltd share?
Based on the latest closing data, the technical momentum for Laurus Labs Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 54.62, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (1451.47) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Laurus Labs Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Laurus Labs Ltd today centers at a Pivot Point (PP) of ₹1588.7. Upside resistance challenges are calculated at R1: ₹1622.5, R2: ₹1643.8, and R3: ₹1677.6. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹1567.4, S2: ₹1533.6, and S3: ₹1512.3.
How does the fundamental ROE and P/E ratio look for Laurus Labs Ltd?
Laurus Labs Ltd is currently trading with a valuation metrics context of a Stock P/E of 79.1, against a core structural efficiency Return on Equity (ROE) standing at 18.3 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 50, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Laurus Labs Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Speculative Momentum Phase (Neutral / Hold). Laurus Labs Ltd is trading above it... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of A, a Relative Strength (RS) ranking of 50, and long-term trend backing from the TI65 indicator (Bullish pattern).